chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recvd vax; devel fever, 3 vesicles of unk location & a red, flat rash over different parts of her body;
Patient development cough, vomiting with meals, fever and low appetite that started the day after receiving vaccines.  Symptomatic care. The fever had resolved at time of visit of 04/12/2022.  Patient's mother was advised to follow up within 1 week of seeing provider.
Pt recv vax on 11/13/98; on 11/15/98 pt exp itching x 2 day
ITCHINESS IN MOUTH AND TONGUE; NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy to shellfish. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 13-MAR-2021 09:30 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-MAR-2021, the subject experienced itchiness in mouth and tongue. On 13-MAR-2021, the subject experienced nausea. On 13-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea on 13-MAR-2021, and had not recovered from fatigue, and itchiness in mouth and tongue. The reporter causality and nausea, fatigue and itchiness in mouth and tongue was possible.  This report was non-serious.
This is a spontaneous report obtained from a contactable pharmacist through a Pfizer sales representative. A female patient of an unspecified age, ethnicity, and race received PREVENAR 13 on an unspecified date, at single dose, for immunization. The patient was underweight. She was on a lot of medication, particularly AIDS medication (all unspecified). On an unspecified date, after the vaccination, the patient experienced dizziness and she was feeling dazed. Clinical outcome of the events was unknown at time of this report.
Information has been received from a consumer concerning her newborn son who on 05-JUN-2009 was exposed to a dose of GARDASIL in utero. The patient was also exposed to prenatal vitamins (unspecified). On 11-FEB-2010 the patient developed tongue tie. It was also reported that during labor the baby grabbed the umbilical cord during contractions, resulting in low oxygen intake. The patient's outcome was unknown. The mother's experience has been captured in WAES # 0906USA01565. Additional information has been requested.
This spontaneous report as received from a physician via a company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 27-JUN-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9 "0.5mL-10 Pk SD PFS-Luer-Lok" which had a lot number of L001312 and expiration date of 24-FEB-2017 (route of administration and anatomical location were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified date, the GARDASIL 9 vaccine had a temperature excursion of 48 hours. The highest recorded temperature was 52 F (11.11111111 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
At site of injection large hive /rash appx. 7 inches in diameter covering about 85% of the top  and inner part of bicep on left arm. The majority of the hive is below the injection site.  The swelled area was very sensitive to touch and very hot and itchy on and around. It occurred between 7-8 days after receiving the vaccination. EmuaidMAX was the treatment used. It has only relieved the symptoms slightly and temporarily.
Daily headaches, swollen lymph nodes in left arm pit and above left collarbone. Increased flow in period and length of time. More painful cramping leading up to menstrual cycle.  Pain in lower left abdomen, random shooting pain that will come and go.
first dose 12 months ago, never received second; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose about 12 months ago).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.    Additional Information: GSK Receipt Date: 15-AUG-2022 Reporter's Comments: The Pharmacist reported that the patient never received his second dose.  The Vaccine Administration Facility was the same as Primary Reporter. Asked about follow up but HCP didn't really say yes or no. Additional Supportive Information: Till the time of reporting patient did not received second dose of Shingrix which led to incomplete course of vaccination.
Left arm injection of vaccine with subsequent left axilla pain and swelling, and left upper arm pain and swelling.
A few weeks after my second vaccine, I was having memory issues. Would forget what I was going to say, lost  my thoughts. Foggy, my brain wasn't able to keep up. It was like everyone talking about the covid brain fog that they had, but as far as I know I did not have Covid. The words are slow! I have talked to my Dr about this and she ran VitB12(920pg/ml) and Folate(40.0ng/ml) and has referred me to psychological tesing. It is better then it was, but still concerning.
Patient developed a slightly warm, red rash around injection site. It is not painful or itchy. It has not disappeared, but has gotten slightly smaller since it first appeared.
Per mother report on 06/16/2017 ~ pt developed swelling, induration and rash to left leg after receiving Hep A.
Happened to be the only time in my life I ever had the flu... 8 days later.; Initial information received on 17-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional via social media.  This case is linked to cases 2020SA294133 (original case) and 2020SA289521 (same document/ reporter)  This case involves patient (unknown gender and age) who reported it happened to be the only time in his/her life ever had the flu, 8 days later (influenza) while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of INFLUENZA VACCINE (batch and expiration date unknown) via unknown in an unknown administration site for prophylactic vaccination.  On an unknown date,(unknown latency) the patients reported that it was happened to be the only time in his/her life ever had the flu, 8 days later (influenza) following the administration of vaccination (non serious).  No laboratory data reported.It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was unknown.  There will no information on the batch number for this case.
Pt made noise like having a BM lasting for approx. 20 min., had shaking, felt cold, then slept. Had high temp.
5 bumps surrounded by redness on R arm (170mm x 40mm). Pt was monitored for 1 hour after adverse reaction. Pt was administered liquid Zyrtec (10mg). Treated and released.
Received the first dose 11/30/2021 and 12/8/2021 I started breaking out in hives all over my face happened a few times for a week and stopped. I received my second dose 1/3/2022 or 1/4/2022 and same thing a week later face starts breaking out in hives again and has been doing so on and off ever since.
This is a spontaneous report from a contactable nurse who reported 10 cases for different patients. This is the 10th of 10 cases. A 78-years-old female patient of an unspecified ethnicity started to receive PREVNAR 13 Lot S15227 Expiry Date 01Feb2018, in Left deltoid, via an unspecified route of administration on 01Feb2017 at 0.5 ml, single for immunisation. Medical history included hypertension from an unknown date and unknown if ongoing High Blood Pressure. The patient's concomitant medications were not reported. The patient experienced bruising at the injection site, swelling at the injection site, small bumps at the injection site on an unspecified date with outcome of unknown. Sender's Comments: Linked Report(s) : US-PFIZER INC-2017083713 same reporter/drug, different patients/event.
Information was received from a lawyer regarding a case in litigation concerning a 48 year old female, who was vaccinated with ZOSTAVAX (dosage and route of administration not provided). On 18-JUL-2013, while at the pharmacy, a pharmacist encouraged the patient to receive an injection of ZOSTAVAX. He did not provide the patient with any information regarding the vaccination and subsequently administered the vaccination without screening the patient or obtaining signed consent. He knew or should have known that the patient has an immunodeficiency from radiation treatment for her breast cancer and that she was not in the recommended age bracket of age 60 or over. He injected the patient with a vaccine that was unreasonably likely to cause her great harm. At the time of the injection, the patient experienced severe pain in her arm at the injection site. Days later, the arm was swollen and she felt excruciating pain. The patient called the pharmacist who assured her that there was no chance she had contracted shingles. She subsequently visited her primary doctor regarding the pain and informed him of the vaccination. Her doctor was shocked to learn that she had been given a ZOSTAVAX as she was clearly not a suitable candidate, and he informed her that she was infected with shingles as a result of the ZOSTAVAX. The patient now suffers from shingles with outbreaks manifesting as large, unsightly rashes which bring terrible pain. The pain interferes with every aspect of her daily life. Plus the shingles infection makes the patient more susceptible to infection and threatens to hinder her recovery should her cancer ever return. The patient must also take VALTREX for the rest of her life to alleviate the symptoms of shingles. The negligence resulted in serious and extensive residual disabilities and permanent damages to the patient including but not limited to: extreme physical pain, large unsightly rashes, anxiety, apprehension, and nausea from the medication she must take to combat the shingles. There is no cure for shingles and the patient must endure the virus for the rest of her life. Shingles, anxiety/apprehension and nausea were considered to be disabling. Additional information has been requested.
my hands started shaking; my heart started racing; I almost passed out; almost passed out; My hands and feet were cold and clammy; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 05Feb2021 12:30 (Lot Number: EN5318) at single dose for COVID-19 immunisation. The patient's medical history was not reported, no known allergies. Patient didn't have COVID prior vaccination. There were no concomitant medications in two weeks. No other vaccines were administered in four weeks. The day after her vaccine her hands started shaking and her heart started racing. She almost passed out. Her hands and feet were cold and clammy. These feeling lasted about 4 hours. Adverse events start from 06Feb2021 03:30 PM. No treatment was received for the events. The outcome of the events was recovered on 06Feb2021 07:30 PM. COVID was not tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Patient presented to the ED and was subsequently hospitalized with acute respiratory failure with hypoxia and hyponatremia within 6 weeks of receiving COVID vaccination.
Received Moderna Covid 19 Monovalent booster instead of Moderna Covid 19 bivalent booster; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT PRODUCT FORMULATION ADMINISTERED (Received Moderna Covid 19 Monovalent booster instead of Moderna Covid 19 bivalent booster) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INCORRECT PRODUCT FORMULATION ADMINISTERED (Received Moderna Covid 19 Monovalent booster instead of Moderna Covid 19 bivalent booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT PRODUCT FORMULATION ADMINISTERED (Received Moderna Covid 19 Monovalent booster instead of Moderna Covid 19 bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT PRODUCT FORMULATION ADMINISTERED (Received Moderna Covid 19 Monovalent booster instead of Moderna Covid 19 bivalent booster).    No concomitant products were reported. No treatment drugs were reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "GERD" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: It was unknown if other medication received in 2 weeks. Paxlovid started on 03Jan2023 and stopped on 07Jan2023 for COVID 19 Treatment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Cellulitis L arm secondary to immunizations. Augmentin 600mg bid 10d started 6/23/05.
8 months since he received the 1st dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 63-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose, 8 months before the reporting date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were reported as follows: The age at vaccination was not applicable for this report. The patient mentioned that, it had been 8 months since he received the 1st dose of the Shingrix Vaccine, which led to incomplete course of vaccination. The patient would like to know if he needed to restart the vaccine series or if he can take the 2nd dose. The reporter consented to follow up.
pt recvd vax;20 mins later exp syncope;1 hr later exp ha,n,v,gastrointestinal sxs;n & v cont x 5 hrs & resolved next day;tx symptomatically w/ tagamet & dph;approx 3 days later seen by MD who stated pt had no rashes;all events resolved;
First night had fever (102.4), chills, body aches, fatigue and slight headache. My arm was sore but my armpit was so painful (felt like stabbing sensation).  This lasted until around 2:00 pm Saturday.  I felt ok except for being tired and armpit still hurting quite a bit. On Sunday, I was very tired and slept during the day and went to bed around 8:30 pm feeling like I had a slight sore throat, tired and mildly nauseous. My armpit still hurt quite a bit.  I woke up Monday at 5:30 am and showered and was profusely sweating when I was getting ready for work - my temperature was 100.6 so I took 800 mg of Ibuprofen to help with the temp and the pain in my armpit.  I did not go into work. I  am still tired and my current temp is 100.1 (12:30pm) and sweaty.  I do feel as though the severity of my armpit pain is lessening but it is still bothersome.
Patient hospitalized with  COVID-19 virus and double pneumonia on 2/5/2022 after having received 3 doses of the COVID-19 vaccine
pt recv vax 3APR96 PM;410AM exp gen malaise, nausea, feels shaky, dizziness, low grade fever, chills
BIT ACHEY; CHILLS; KNOCKED ME OUT FOR A DAY AND SLEPT 15 HOURS/SLEPT UNTIL NOON; .This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex, race and ethnicity The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient previously received covid-19 vaccine ad26.cov2.s vaccination from an unspecified manufacturer (dose number in series: 1) for prophylactic vaccination. No events reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose was not reported, (dose number in series: 2) start therapy date were not reported, 1 total administered, for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced knocked me out for a day and slept 15 hours/slept until noon, chills, and bit achey (dose number in series: 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the knocked me out for a day and slept 15 hours/slept until noon, chills and bit achey was not reported. This report was non-serious.
Pain in upper arm, but no swelling or heat at site of injection.  Some tingling in fingers of left hand. Shot was given in very upper right arm, very close to shoulder.
Patient experienced severe nausea and dizziness in the evening on 3/9/21 and lost consciousness in her kitchen.  She was taken to the ER the next morning and was diagnosed with a pulmonary embolism and acute DVT in the right popliteal vein and right calf veins.   Patient was treated with EKOS and discharged on 3/13/21 on Apixiban.
Temperature to 103 F with nausea/vomiting x 24 hours after receiving vaccines.
My right hand is peeling on the right side below my pinky finger and the inside of my hand on my thumbside.
Vaccine at 0900; itchy eyes by 0950; lips swelling than face. Got hives on face and rest of body itchy.  Took 25 mg Benadryl  at 1015.  By 1130 hives were gone but itching continued. Used eye allergy relief. Lips swollen for 24 hours. No shortness of breath. At 2100 got rapid heart rate till about 2130. Resolved. Continued having itchy skin and eyes for 4 days. On 01/14/2021 started fexofenadine 180 mg one per day and used eye drops as needed for itchy eyes
Information has been received from a nurse practitioner concerning 3 children who was vaccinated with GARDASIL. The nurse practitioner reported that a mother of her patient informed her that 3 children in her patient's high school developed guillain-barre syndrome after receiving GARDASIL. The patient refused and did not get the GARDASIL for this reason. Upon internal review, Guillain-Barre syndrome was considered to be an Other Important Medical Event. Attempts are being made to verify the existence of an identifiable patient and reporter. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information has been requested.
Participant reported incident on 11/6/17 stated that when she had her flu shot on 10/25/17 at around 1:00 PM later that night she started experiencing severe pain in her left arm where shot was given. The area became black and blue and she had to see her primary physician for the pain. Patient stated that she is going for and xray and ultrasound. Patient continues to have severe pain and is unable to sleep at night. 12/7/17 spoke with patient regarding which arm flu shot was given in she stated it was definitely the left arm. Sign consent was for right deltoid. Participant claims she had her bursa drained and is taking cortisone shots and is out of work.
Diarrhea;  several episodes of heart arrhythmia on two different days starting 10 days after second COVID-19 vaccine injection.    Although I am predisposed to heart arrhythmia having been diagnosed with super ventricular tachycardia in late teen years, then atrial fibrillation starting at age 60,  I was getting an episode of a-fib only once every 3-4 months following an ablation procedure.   This was different as I had several episodes in a day on two different days.  They subsided only following the taking of propafenone.
My son immediately went into a 2 month long flare after receiving the vaccine. Cramping, nausea, joint pain, had to walk with a cane & missed much school.
Interchange of vaccine products; This spontaneous case was reported by an other health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ALBUTEROL [SALBUTAMOL], LEVOTHYROXINE, METOPROLOL TARTRATE, ATORVASTATIN and CLOPIDOGREL for an unknown indication.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). On 07-Apr-2021, INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were provided. No concomitant medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 09-Apr-2021: 1st dose and 2nd dose information were updated, concomitant medication were added. Patient information was updated.
Pt received both doses of the Pfizer COVID-19 vaccine on 12/28/2020 and 1/16/2021.  On 7/19/2021, he called in to his PCP's office to report loss of taste and small, low grade fever, coughing, sore through, and "feeling like he has a sinus infection".  He was tested via PCR for COVID-19, which resulted positive.  Pt thus far has not needed further medical attention.